Current status of injectable agents for female stress urinary incontinence.
The purpose of this review is to summarize the results of reports of injectable agents for the treatment of female urinary stress incontinence. Five agents were reviewed: collagen, Teflon, autologous fat, silicone microparticles, and silicone microballoons. Collagen was the most frequently reported agent and yielded short-term cure and improved rates of 74%-100%. This deteriorated to approximately 57% with longer term follow-up. Teflon has similarly lower longer term than short-term success rates, at 33%-76%. The reported local complications and the potential for particle migration have resulted in its lack of widespread acceptance. Autologous fat has yielded the lowest success rate. Longer term success in a small number of silicone microparticle articles was similar to the other injectables at approximately 60%. Early success with silicone microballoons was 70%. The technique is generally free of major morbidity. The indication for injectables is intrinsic sphincter deficiency but hypermobility is not a contraindication. Long-term durability, cost effectiveness, and some safety issues still have to be addressed by further clinical trials.
Herschorn
S
S
Division of Urology, University of Toronto, Sunnybrook and Women's Health Sciences Centre, 2075 Bayview Avenue, Toronto, Ontario M4N 3M5, Canada.
D000273:Adipose Tissue / Q000637:transplantation; D001672:Biocompatible Materials / Q000008:administration & dosage*; D003094:Collagen / Q000008:administration & dosage / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D007267:Injections / Q000379:methods; D018579:Patient Selection; D011138:Polytetrafluoroethylene / Q000008:administration & dosage; D019736:Prostheses and Implants; D012826:Silicone Elastomers / Q000008:administration & dosage; D014550:Urinary Incontinence, Stress / Q000628:therapy*
D001672:Biocompatible Materials; C075314:GAX-collagen; D012826:Silicone Elastomers; D011138:Polytetrafluoroethylene; D003094:Collagen